Skip to main content

Table 2 Treatment outcomes

From: Efficacy and safety of edoxaban tosylate hydrate 15 mg in the prevention of venous thromboembolism in patients with impaired renal function after orthopedic surgery of the lower extremities

  Edoxaban 15 mg (n = 23) Edoxaban 30 mg (n = 209) p value OR (95% CI)
Proximal DVT 0 0 1.00 0
Distal DVT 2 (8.7%) 18 (8.6%) 1.00 0.99(0.22–4.56)
PTE 0 0 1.00 0
  1. CI, confidence interval; DVT, deep venous thrombosis; OR, odds ratio; PTE, pulmonary thromboembolism